Neil Stowe

Neil Stowe is an accomplished scientist with extensive experience in bioorganic chemistry and immunoassay development. Currently serving as Principal Scientist at Psychemedics Corporation since July 2014, Neil Stowe leads the development of assays from feasibility studies to FDA approval, managing a laboratory team in production and regulatory compliance. Prior experience includes a role as Research Scientist at Alere, Inc., where Neil Stowe designed small molecule haptens for drug detection assays, and as a Postdoctoral Research Associate at The Scripps Research Institute, where Neil Stowe developed a vaccine targeting heroin addiction. Neil Stowe holds a PhD in Bioorganic Chemistry from the University of Florida and a BS in Chemistry from Delta State University.